Go to main navigation Go to main content Go to footer

A phase II randomized, double-mask study to establish the safety and efficacy of high-dose oral omega 3 in subjects with geographic atrophy secondary to dry age-related macular degeneration

The objectives of this study are to evaluate the safety and efficacy of High-Dose Oral Omega 3 on the Photoreceptors/Retinal Pigment Epithelium/Bruch’s membrane complex in subjects with geographic atrophy secondary to age-related macular degeneration and to evaluate whether improvement in visual function occurs and progression to advanced stages of AMD is delayed.

untitled

untitled

untitled

Research is the only solution for the future to fight against blindness

It is only with your help that we can fight against blindness

Collaborate